Paul Modlinger
Impact in
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
- Nephrology top 5%
Papers in
-
- Eicosanoids and Hypertension Pharmacology 5
-
- Renin-Angiotensin System Studies 3
- Co-authors
- Christopher S. Wilcox (6 shared papers)Shakil Aslam (3 shared papers)William J. Welch (6 shared papers)Margarida Mendonca (3 shared papers)Tinatin Chabrashvili (2 shared papers)Noritaka Kawada (3 shared papers)Anton Wellstein (1 shared paper)David G. Harrison (1 shared paper)
- Journals
- Hypertension (2 papers)Gastroenterology (1 paper)Current Opinion in Nephrology & Hypertension (1 paper)American Journal of Physiology-Renal Physiology (1 paper)Seminars in Nephrology (1 paper)
- Partner nations
- United StatesJapanNorway
In The Last Decade
Paul Modlinger
9 papers receiving 667 citations
Peers
Comparison fields: 5 of 74
- Biochemistry 119
- Nephrology 81
- Physiology 249
- Cardiology and Cardiovascular Medicine 184
- Physiology 40
Countries citing papers authored by Paul Modlinger
This map shows the geographic impact of Paul Modlinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Modlinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Modlinger more than expected).
Fields of papers citing papers by Paul Modlinger
This network shows the impact of papers produced by Paul Modlinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Modlinger. The network helps show where Paul Modlinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Modlinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 247 | |
| 2 | 2006 | 122 | |
| 3 | 2007 | 118 | |
| 4 | 2003 | 65 | |
| 5 | 2004 | 57 | |
| 6 | 2005 | 28 | |
| 7 | 2007 | 27 | |
| 8 | 2001 | 23 | |
| 9 | 2000 | 2 |
About Paul Modlinger
Paul Modlinger is a scholar working on Biochemistry, Cardiology and Cardiovascular Medicine, Physiology, Oncology and Molecular Biology, having authored 9 papers that have together received 689 indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (5 papers), Nitric Oxide and Endothelin Effects (4 papers), Renin-Angiotensin System Studies (3 papers), Colorectal Cancer Screening and Detection (2 papers), Radiomics and Machine Learning in Medical Imaging (1 paper), Pancreatic and Hepatic Oncology Research (1 paper), Adenosine and Purinergic Signaling (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Biochemistry (119 citations), Nephrology (81 citations), Physiology (249 citations), Cardiology and Cardiovascular Medicine (184 citations) and Physiology (40 citations). Paul Modlinger has collaborated with scholars based in United States, Japan and Norway. Frequent co-authors include Christopher S. Wilcox, Shakil Aslam, William J. Welch, Margarida Mendonca, Tinatin Chabrashvili, Noritaka Kawada, Anton Wellstein, David G. Harrison, Kathy K. Griendling and Min Li. Their work appears in journals such as Hypertension, Gastroenterology, Current Opinion in Nephrology & Hypertension, American Journal of Physiology-Renal Physiology and Seminars in Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.